Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly
170 million infected individuals worldwide. Current treatment for chronic infection is a …

The pathogenesis of hepatitis C virus (HCV) infection is strongly influenced by the nature of
the host's antiviral immunity. Counterintuitively, elevated serum concentrations of C‐X‐C …

Chemokine (C‐X‐C motif) ligand (CXCL) 10 and other CXCR3 chemokines are involved in
the pathogenesis of acute and “chronic hepatitis C virus (HCV) infection”(CHC). Here, we …

Chronic infection with the hepatitis C virus (HCV) is associated with failures of T-cell–
mediated immune clearance and with abnormal B-cell growth and activation. We examined …

To investigate chemokine expression networks in chronic hepatitis C virus (HCV) infection,
we used microarray analysis to determine chemokine expression in human infection and in …

Background CXCR3-associated chemokines CXCL9–CXCL11 promote histologic
progression in chronic hepatitis C virus (HCV) infection, as indicated by elevated …

An estimated 170 million people worldwide are chronically infected with the hepatitis C virus
(HCV), which is characterized histologically by a persistent immune and inflammatory …

Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection is accompanied by
inflammation and fibrosis eventually leading to cirrhosis. The chemokine CXCL12 is …

Hepatitis C virus (HCV) is a leading cause of chronic liver disease that can progress to
cirrhosis and/or hepatocellular carcinoma. Intrahepatic inflammation and liver cell injury are …

Aberrant expression of the chemokine CXC chemokine ligand (CXCL) 10 has been linked to
the severity of hepatitis C virus (HCV)‐induced liver injury, but the underlying molecular …